TP53 and endometrial cancer: Recently, a comprehensive study evaluating histology, molecular landscape, and the clinical behavior of multiple-classifier cancers has shown that TP53 mutations can occur as a secondary event in the context of the 'mutators' mismatch repair deficiency and POLEmut endometrial cancers, without affecting outcome.